Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial ribosome’s A-site RNA—specifically helix 44 within its universally conserved 16S rRNA—is central to accurate decoding during protein synthesis. It forms part of both functional centers for tRNA selection at the aminoacyl site and interfaces with key translational factors that regulate start codon recognition. Its unique structure makes it an attractive target for antibiotics that disrupt prokaryotic but not eukaryotic translation machinery.
Inhibition of bacterial protein synthesis
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial Ribosome A-site RNA (Helix 44, 16S rRNA) (h44 16S rRNA).